The store will not work correctly when cookies are disabled.
2,7-diacetamino-9-fluorenone
ID: ALA3740772
PubChem CID: 285260
Max Phase: Preclinical
Molecular Formula: C17H14N2O3
Molecular Weight: 294.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)Nc1ccc2c(c1)C(=O)c1cc(NC(C)=O)ccc1-2
Standard InChI: InChI=1S/C17H14N2O3/c1-9(20)18-11-3-5-13-14-6-4-12(19-10(2)21)8-16(14)17(22)15(13)7-11/h3-8H,1-2H3,(H,18,20)(H,19,21)
Standard InChI Key: HTJDCIVXTYRBND-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
0.0000 -1.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2274 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2274 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4915 -1.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7006 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7006 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4915 1.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2274 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2274 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4732 1.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7372 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7372 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4732 -1.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.5190 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0356 -1.3582 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.0029 -1.3524 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0332 -2.8591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9928 -3.4571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0711 -3.4614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.3014 -0.5998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.3420 -1.1974 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.2991 0.6002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 9 1 0
8 1 1 0
1 3 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
1 14 2 0
12 15 1 0
5 16 1 0
15 17 1 0
17 18 1 0
17 19 2 0
16 20 1 0
20 21 2 0
20 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.31 | Molecular Weight (Monoisotopic): 294.1004 | AlogP: 2.81 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.27 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.69 | CX Basic pKa: ┄ | CX LogP: 1.58 | CX LogD: 1.58 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.76 | Np Likeness Score: -0.49 |
References
1. Lee S, Esteva-Font C, Phuan PW, Anderson MO, Verkman AS.. (2015) Discovery, synthesis and structure-activity analysis of symmetrical 2,7-disubstituted fluorenones as urea transporter inhibitors., 6 (7): [PMID:26191399] [10.1039/c5md00198f] |
2. Titko T, Perekhoda L, Drapak I, Tsapko Y.. (2020) Modern trends in diuretics development., 208 [PMID:33007663] [10.1016/j.ejmech.2020.112855] |